-
Xeris Pharmaceuticals Inc. (XERS) Prices 9M Share Common Offering at $4.15/Sh
-
Xeris Pharmaceuticals Announces Pricing of Public Offering of Shares of Common Stock
-
Xeris Pharmaceuticals Announces Pricing of Public Offering of Shares of Common Stock
-
Xeris Pharmaceuticals Inc. (XERS) to Offer 6M Shares
-
Xeris Pharmaceuticals Announces Proposed Public Offering of 6,000,000 Shares of Common Stock
-
Xeris Pharmaceuticals Announces Proposed Public Offering of 6,000,000 Shares of Common Stock
-
Xeris Pharmaceuticals Announces First Quarter 2019 Financial Results and Highlights Its Pipeline
-
Xeris Pharmaceuticals Announces First Quarter 2019 Financial Results and Highlights Its Pipeline
-
Xeris Pharmaceuticals Inc. (XERS) Prices 5.8M Share Common Offering at $10/Sh
-
Xeris Pharmaceuticals Announces Pricing of Public Offering of Shares of Common Stock
-
Xeris Pharmaceuticals Announces Pricing of Public Offering of Shares of Common Stock
-
Xeris Pharmaceuticals Inc. (XERS) Announces Proposed 5M Share Common Offering
-
Xeris Pharmaceuticals Announces Proposed Public Offering of Shares of Common Stock
-
Xeris Pharmaceuticals Announces Proposed Public Offering of Shares of Common Stock
-
UPDATE: RBC Capital Starts Xeris Pharmaceuticals (XERS) at Outperform
-
Xeris Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Xeris Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Xeris Pharmaceuticals (XERS) IPO Opens 5% Higher
-
Xeris Pharmaceuticals, Inc. (XERS) Prices 5.7M Shares IPO at $15/Sh
-
Xeris Pharmaceuticals Announces Pricing of Initial Public Offering of Common Stock
-
Xeris Pharmaceuticals Announces Pricing of Initial Public Offering of Common Stock

